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SOME FUNDAMENTALS OF GONADAL DEVELOPMENT
AND FUNCTION*
RICHMOND W . S M I T H , JR.,

M.D.**

AND RAYMOND C .

MELLINGER,

M.D.**

The traditional division of animal life into male and female forms is based
on obvious biological differences, but these distinctions become less striking when
we realize that life, in a sheer physico-chemical sense, is a spectrum of sexuality
that maleness and femaleness are relative terms. Our conceptual devotion to a
two compartment universe is apparent in many areas of life, sociologic, moral, legal,
spiritual or biologic. Although reproductive obligations remain clear, albeit increasingly
restricted, man's greater social sophistication is molding an order in which underlying
biological distinctions of the two sexes are sometimes obscured by the potent solvents
of culture, leisure and intellect. The purpose of this essay is to review some fundamental
aspects of gonadal development and function, presenting similarities as well as
differences between the male and female forms. Since few areas of biology have
been favored with such significant contributions as have come recently to the
fields of genetics and embryology, it is logical to begin with a brief review of these
before discussing the prevailing concepts of gonad endocrinology.
The classical concept that the germinal epithelium of the vertebrate gonad has
its origin in the primitive coelomic epithelium has been challenged by the Weismann'
viewpoint which has received support in the studies of Fuss^ Witschi' and McKay
et al.'' It proposes that the primordial germ cells, arising de novo in the yolk sac
endoderm, migrate through the mesenchyme to their final destination and become the
fetal gonad. As shown in Figure 1 the hormone-producing structures of ovary, testis
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Figure 1
Embryologic derivation of adrenal and gonadal tissue.
and adrenal are derived from one select area of the mesoderm which might be labeled
the steroid-gland primordium. The gonadal ridges are apparent in the human embryo
at about the fourth week of fetal development, and until the seventh week the
gonads of the genetic male and female embryos are indistinguishable (see Fig. 2 ) .
Fusing of the bipotential primordial germ cells with the hormonal cells of mesodermal
origin results in the embryonic gonad, consisting of the primary sex cords surrounded
*Presented in part at the Eighth Annual Graduate Symposium on the Dynamics of Endocrine and
Metabolic Disease sponsored by Highland-Alameda County Hospital, Oakland, California, Feb 1960
** Division of Endocrinology.
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Figure 2
Embryologic development of the human gonad. Male and female structures are indistinguishable
until after the 7th week (from Barr.s by permission of the author).
by the cortex. At this critical junction the fate of the indifferent gonad is decided
by subtle forces which have been termed "inductors". As stated by Barr,' germ
cells assume the male or female sex character not because of their respective genie
make-up but in response to inductive stimuli. Simultaneously, gonia begin differentiation along spermatogenetic hnes if originally located in the medulla, or along ovogenetic
lines if the primordial germ cells reside in the gonadal cortex. At about the seventh
week in embryos of X Y chromosomal complex, the medulla begins to develop and
the cortex to regress while the sex cords, differentiating to early seminiferous tubules,
are interspersed with interstitial cells. The gonadal cortex in male embryos develops
ultimately into the thin, visceral layer of the tunica albuginea. At the eighth or
ninth week of embryos with X X chromosomal pattern, the gonadal cortex is invaded
by sex cords, the medulla regresses and the gonad develops into an ovary. Disruption
of the critical differentiation in the bipotential gonad at this point may result in sex
anomalies. Such interference may be the result of a mutant gene, a defective
chromosome carrying sex determiners, or a nongenetic factor such as a chemical
or hormone, either of endogenous or exogenous origin.
Experimental grafting of embryonic rat ovary and testis into castrated adult
hosts results in suppression of the differentiation of the embryonic ovary while the
testis remains unaffected.'-' Holyoke and Beber= augmenting these experiments, made
tissue cultures of the paired embryonic gonads from both rabbit and rat. The
embryonic testes grew well in all combinations, whereas development of ovaries
cultured with young testes was markedly retarded (Table I . ) . In some instances
masculinizing effects occurred as shown by the presence in ovaries of testicular
cords in the medullary portions. It was deduced that the embryonic testis produces
a substance capable of altering the embryonic ovary. That this substance is a
hormone distinct from adult male hormone is concluded from the observation that
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Table I
Effects of Hormonal Environment on the Development of the Mammalian Ovary
(rat and rabbit embryos)*
Host

Hormonal Environment

Ovary Development

Castrate adult male

O

normal

Intact adult male

male hormone

normal

Intact adult male

testis

normal

Castrate adult male

embryonic ovary

normal

Castrate adult male

embryonic testis

retarded

Organ culture

embryonic ovary

normal

Organ culture

embryonic testis

retarded

*based on report of Holyoke and Beber.8
the same embryonic ovary can develop normally in an adult male even when
grafted to the host testis.
The secondary sex structures, already in existence when gonadal differentiation
begins, also have a developmental bipotential (Fig. 3). The ovaries are apparently
indifferent gonad
Wolffian duct
Mullerion duct
urogenital sinus
normal

Q\ \

prostate

Figure 3
Development of the sex ducts in normal and gonadectomized rabbit embryos (from Jost,' by courtesy
Cambridge University Press).
not essential for continuing differentiation and growth of the Miillerian system but
the embryonic testis, through a presumed hormonal inductor, is critical for Wolffian
duct maturation. Barr' has stated "the requirement of a masculine evocator of
testicular origin to counteract a tendency of all embryos to feminize is a keystone
in current concepts of the pathogenesis of congenital errors of sex development". The
inherent feminizing propensity of embryos seems genetically regulated and not the
result of maternal estrogen or some exogenous factor. The genes involved must
326
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not be those for the male and female determiners of gonadal differentiation since
female duct development can occur even in the absence of a normal X X sex chromosome complex and a maturing ovary. Finally, from recent studies of patients with
sexual anomalies it appears that the Y chromosome is not genetically passive but carries
potent male-determining genes.
The development of a histologic test for sex chromatin determination has contributed greatly to the understanding of the mechanisms involved in both normal
and abnormal sex differentiation. This relatively simple technique, introduced by
Moore and Barr'" in 1953, makes possible the accurate recognition of chromosomal
sex, thus providing the critical link between gonadal morphology and phenotype in
man. The feature which identifies the nuclei of females is a large, dense chromatin
particle, usually in proximity to the nuclear membrane and found often to be a
bipartite body. In properly prepared sections of female tissue it can be identified
in 60 to 70 per cent of the nuclei. Barr= states that the densely staining body
probably represents the heterochromatic regions of the two X chromosomes. Its
presence, however, does not necessarily mean a normal X X structure since unusual
chromosomal complexes have been described for patients with Klinefelter's syndrome
( X X Y ) " and for the "super-female" individual ( X X X ) " . Conversely, its absence

Figure 4
Microscopic (X400) structure of an ovary from a fetus 25 weeks old (ovulation age). Primordial
germ cells and 'nurse' cells are almost indistinguishable in cortical area (right upper half of
photograph). Germ cells are better differentiated from 'nurse' cells in lower half of the section
where the latter are seen surrounding the primordial ova.
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indicates that two X chromosomes are not present, which could mean either a
normal X Y complex or an abnormal XO structure (Turner's syndrome).
DIFFERENTIATION A N D MATURATION OF THE OVARY
In the normal subject with X X chromosome complex, the joining of the germ
cells and mesenchymal hormonal cells at the locus of the fetal gonad results in
the maturing ovary. In Figure 4, taken from a publication by Garcia and Rock,'^
are shown the primitive elements in an ovary of a 25 week old fetus. The mesenchymal
interstitial cells, or "nurse" cells, are the precursors of the granulosa cells which
eventually surround each primordial ova. By the time of birth neariy all germ
cells have been so surrounded. The actual number of primordial follicles existing
at birth appears to vary widely but approximates 200,000 per ovary. Only a small
fraction show any signs of further maturity. The weight of evidence favors the
idea that aging of the ovary begins at birth and no new primordial ova are formed,
the attrition through ova-death or ovulation progressively depleting the gonad. By
age 40 to 50 only a few thousand primordial follicles can be found. A progressive
thinning of the cortex ensues, the surface wrinkles and the medulla appears relatively
conspicuous, having become the repository for multiple corpora albicantia.
It is generally held that FSH accelerates the growth and maturation of the
ovarian follicles through its effect on the granulosa cells which, surrounding each
ovum throughout fetal and juvenile life, have promoted a slow process of follicular
maturation (Fig. 5). As granulosa cell activity increases, a local stimulus results
Secondary

Oocyte

G ra nulosa

Figure 5
Schematic representation of the micro-anatomy of the ovary, showing follicular maturation and
structure of the Graafian follicle.

in the formation of a surrounding theca interna which in turn autonomously elaborates
estrogen as estradiol. This hormone now becomes the key factor in further gonadal
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and folhcular growth. It directly affects the amount and composition of the
follicular fluid, while the follicle expands eccentrically, forming the antrum and the
Graafian follicle. The FSH-induced increase in estrogen production by the follicle
provokes the pituitary into releasing the luteinizing hormone which in combination
with FSH furthers the follicular maturation. The theca interna begins elaborating
small amounts of progesterone, the follicle becomes distended and the stage is set
for ovulation. At this point the action of the third tropic substance, luteotropin or
prolactin, leads to release the ovum. During this time the ovogonium has matured
through mitotic and reductional division to a secondary oocyte with 23 chromosomes.
This cell is approximately five to seven times larger than the primordial germ cell,
excluding the zona pellucida. The exact hormonal chain of events at dehiscence of
the follicular wall is not known. Luteinization of the ruptured follicle follows, and
with this proliferation of hormonally active cells, increased amounts of estrogen and
progesterone are produced. FSH release by the pituitary is suppressed and luteotropin
dominates ovarian control with emphasis on progesterone formation until the end
of the luteal phase.
That this chain of events applies to man is still unproved since gonadotropin
assays have not been perfected to the degree that luteotropin can be separated with
confidence from FSH and L H in human urine. Furthermore, the experimental
induction of ovulation in primates has proved difficult, Knobil et al" only recently
having reported the achievement in one hypophysectomized Rhesus monkey receiving
thyroid, primate FSH and human chorionic gonadotropin. The capacity of purified
FSH alone to induce marked follicular hypertrophy, however, has been amply
demonstrated both in primate and infra-primate species. In a 1958 report from Sweden,
Gemzell and associates" claimed that the injection of human pituitary FSH followed
by chorionic gonadotropin produced polycystic ovaries and ovulation in amenorrheic
women.
Progress in the isolation, purification and characterization of pituitary gonadotropins, especially from human sources, has been disappointingly limited."" Small
amounts of highly purified sheep FSH and L H are becoming available, and data
are accumulating from the comparative assays of these substances with human
urinary gonadotropins."-" Yet the latter are excretory products and thus may be
chemical disfigurements of the original pituitary secretion. As long as bioassay in
animals remains the best assay procedure, varying as it does from laboratory to
laboratory, and as long as the source and methods of isolation and purification differ
widely, the identity and functional interrelationships of human gonadotropins will
not be readily resolved. In Figure 6 are graphed the results obtained in our laboratory
for the comparative properties in the immature mouse of human gonadotropins
from urine of postmenopausal women and young men, and of purified folliclestimulating hormone from sheep pituitaries. Although no differences in biologic
response under conditions of this assay could be demonstrated between the human
urinary gonadotropins, the sheep FSH produced a significantly different response.
This difference, which has not been explained, may be due to species specificity or
to the result of metabolic tranformation or alterations produced in preparation of
the hormone.
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Figure 6
Comparative effects of human urinary gonadotropins and sheep pituitary FSH in the immature
mouse uterine weight assay. The slopes of the dose-response curves are significantly different.
DIFFERENTIATION A N D M A T U R A T I O N OF T H E TESTIS
The three main cellular components of the developing testis are the germinal
epithelium, the Sertoli cells and the interstitial cells of Leydig. In Figure 7 is
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Figure 7
Schematic representation of the micro-anatomy of the mature human testis.
presented in schematic fashion the microscopic differentiation of the major components
of the adult human testis. The germinal epithelium of the late fetal and infantile
gonad is well developed, and except for the lack of spermatogenesis, the architecture
is essentially that of the adult. The seminiferous tubules are solid i.e. lacking a
central tubular lumen, and the germinal epithelium consists of resting spermatogonia.
Spermatogenesis begins at age 11 to 18 years and continues well into the
sixth decade of life or beyond. The chain of events producing the spermatozoa
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involves both a primary and secondary maturation division. The development of the
spermatocytes containing 46 diploid chromosomes is believed to occur in response
to local hormonal stimulation. In man this maturation is dependent upon gonadotropic
hormones, but in the rat it is known to proceed without FSH. The miotic division
to secondary spermatocytes with 23 chromosomes also apparently depends on FSH
action, but whether this is a direct effect or is mediated through the Sertoli cells
remains to be established.
The true function of the Sertoli cells in man is unknown, but they appear
intimately involved in the process of sperm maturation, possibly serving as a nutrient
source. One school, perhaps dominant, attributes testicular estrogen production to
the Sertoli cells, while others have reported evidence which assigns this function
to the interstitial cells. Whatever is produced, be it substance " X " of Howard'" or
estradiol, the Sertoli cell often shows histologic evidence of secretory activity, and'
in the dog, Sertoli cell tumors are often highly productive of estrogens.
The third functional element of the testis, the interstitial cell of Leydig, is
the major site of hormonal production. Well developed in the embryo, the interstitial
cells undergo a period of relative dormancy from birth to puberty at which time
a resurgence of hormonal activity occurs. That this function is controlled by the
pituitary through the luteinizing hormone ( L H ) is a universally accepted concept.
BIOGENESIS OF GONADAL HORMONES
Among the recent significant developments in endocrinology has been the elucidation of the biosynthetic pathways of the gonadal hormones. It has long been
held that estradiol is the chief estrogen produced in the ovary, that testosterone is
the testicular androgen and that estrogens and androgens of lower potency arise in
the adrenal cortex. There is evidence for estrogen production by the human testis
but that for androgen synthesis in the human ovary is less conclusive.
The basic pattern of chemical events in the biosynthesis of both adrenal and
gonadal steroids (Fig. 8) has been deciphered primarily through studies of patients
with hyperfunctioning neoplasms of endocrine glands. As depicted by Dorfman,''
the chief substrate, acetate, undergoes a series of molecular couplings yielding
cholesterol. Probably initiated by the action of pituitary tropic hormones on specific
enzymes, cholesterol undergoes a side-chain hydrolysis and cleavage, with oxidation
of C20, to become pregnenolone. The next steps, common to the biosynthesis of all
adrenal and gonadal steroids, are the oxidation of pregnenolone through the action
of 3)8-01-dehydrogenase to progesterone, and the 17a-hydroxylation of the latter
compound to 17a-hydroxyprogesterone. The recent report by Landau" that administration of large amounts of chorionic gonadotropin to intact males results in
an increased excretion of pregnanetriol (a urinary metabolite of 17-hydroxyprogesterone), supports the concept that 17-hydroxyprogesterone is an intermediate in
testicular steroid biosynthesis. This latter steroid in turn undergoes oxidative removal
of the side chain at C17 yielding a 19-carbon steroid, A''-androstene-3:17-dione and
acetic acid. Testosterone results from reduction of the Ci? ketone group to a 17/3hydroxyl group. The major urinary metabolites of testosterone are androsterone,
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Figure 8
Chemical pathways in the biosynthesis of the adrenal and gonadal steroid hormones,
as proposed by Dorfman.^'

epiandrosterone, androstane 3, 17-dione and three etiocholanes:
17a-diol and 3a-ol, 17-one.

3, 17-dione, 3a,

As previously mentioned, the interstitial cells of the testis are the locus of
androgen biosynthesis in the male. That testosterone is actually produced in the
human testis has been demonstrated in recent years by Lucas and associates'^ who
isolated the hormone from the spermatic vein. Hollander and co-workers" more
recently confirmed this observation and found a progressive decrease in concentration
of the hormone with age. Although no pure androgen has been recovered from the
ovary, androgenic activity in ovarian extract was demonstrated 20 years ago.'^
More recently, Johnson" has demonstrated that implanted ovaries in parabiotic male
castrate rats when stimulated with gonadotropins can maintain the male secondary
sex characteristics. It is probable that androgens are synthesized in the ovary in a
manner similar to that described for the testis. Baggett and co-workers'' have
demonstrated in human ovarian tissue the conversion of C"-labeled testosterone to
17/3-estradiol.
That the adrenal cortex secretes androgenic steroids is evident in the sharp
increase in urinary 17-ketosteroids which occurs in the puberal period. That a
major portion of these ketosteroids are of adrenal origin is apparent in the marked
reduction in their excretion which occurs during adrenal-suppressive therapy with
the glucocorticoids. During early adult years, women excrete approximately 30
per cent less urinary androgens and 17-ketosteroids than do contemporary males.
No quantitative change has been observed during the menstrual cycle. Shown in
Figure 9 are data concerning the widely recognized decline in urinary neutral
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Figure 9
Composite of urinary 17-ketosteroid excretion of 147 women,
normals and osteoporotics, studied by the authors.

17-ketosteroid excretion which occurs with age. A similar progressive lowering of
17-ketosteroid excretion ocurs in the aging male. The studies of Pincus and
associates'" have shown that this decline in ketosteroid excretion for both sexes
is much greater for the 11-deoxy fraction than for the 11-oxygenated steroids. That
this is a change in adrenocortical steroidogenesis and not a result of waning ovarian
secretion is suggested by the fact that bilateral oophorectomy in the pre-menopausal
female does not significantly reduce the urinary 17-ketosteroid level. It could be
interpreted as suggesting that the primary function of Cortisol biosynthesis requires
progressively less pituitary ACTH as the individual ages, resulting in a proportional
decrease in androgen secretion. In that sense, adrenocortical function in the aged
is the reverse of that seen in patients with congenital virilizing adrenal hyperplasia
a syndrome in which deficient Cortisol production permits excessive ACTH release
and accelerated adrenal androgen formation.
In the young woman, estradiol biosynthesis probably occurs for the most part
in the theca interna, possibly in the granulosa cells. When the ovary atrophies at
menopause, however, these structures are replaced by functionless corpora albicantia,
and the interstitial stroma remains as the only potential source of gonadal estrogens.
That the adrenal cortex contributes estrogen is beyond question, but the extent and
biological significance of this secretion (probably estrone) are not entirely known.
The three major estrogens are 17;8-estradiol, estrone and estriol (Fig. 10).
17^-Estradiol is considered the parent compound, while estrone and estriol are its
metabolic derivatives. Experimental evidence indicates that estriol can not be converted to estrone or estradiol, although interconversion between estradiol and estrone
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Figure 11
Urinary estrogen levels during the menstrual cycle (adapted from Brown^').

is possible. In urine estriol constitutes from 50 to 70 per cent, estrone 20 to 40
per cent and estradiol 12 to 15 per cent of the total estrogens, expressed in micrograms
per day. The excretion values for these three substances during typical menstrual
cycles are shown in Figure 11, data for which have been taken from the studies
of Brown."
With advancing years women excrete progressively smaller amounts of all estrogens,
with a fairly rapid drop occurring iti the fourth decade. The greatest reduction occurs
in the estriol fraction. This change; is shown in Figure 12, representing data from
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Urinary excretion of estrogens by men and women, from
maturity to senescence (adapted from Pincus^s).

the published studies of Pincus and associates." These investigators demonstrated
that by the time of menopause, total urinary estrogen levels were no greater than
those found in the urine of men of comparable age. The great difference between
the sexes in the fourth to sixth decades of life was the progressive rise in the estriol
fraction of male urine. Based on this observation, the authors suggested that age
effects the metabolic conversion of estrogens differently in the two sexes.
These data concerning estrogen excretion by women 20 to 40 years postmenopausal have been confirmed by others, but whether such estrogens are the products
of the postmenopausal ovary is open to question. Wotiz and associates^" have
reported the in vitro conversion of C^-labeled testosterone to estrone, estriol and,
to a lesser extent, estradiol by tissue obtained from the ovary of a woman 20 years
postmenopausal. The stroma of this ovary was described as being hyperplastic. Such
evidence might be considered to support the theory of Sommers^' that stromal
hyperplasia in postmenopausal women represents a functioning tissue, the presence
of which can be correlated with the occurrence of breast carcinoma. On the other
hand, West and co-workers^' have demonstrated in castrated, adrenalectomized women
the conversion of testosterone to estrogens, a process presumably occurring in the
liver. Paulsen and associates'^ administered hog FSH to six intact, postmenopausal
women and found in two an increased excretion of urinary estrogens, measured by
biological assay. These authors observed that the level of urinary estrogens of
intact postmenopausal women were about twice that of contemporary castrates.
McBride" of Scotland reported in 1957 that the quantity of the three major estrogens
in urine of women averaging 10 years postmenopause was comparable to that of
women at the low point in the menstrual cycle. No cyclic variation was noted
in the former group, and the level of estrogen was unrelated to the histologic pattern
of the endometrium. Furthermore, bilateral oophorectomy in postmenopausal women
led to no reduction in levels of urinary estrogens.
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Gynecologists and internists long have recognized clinical evidence that great
differences exist in levels of ovarian function in postmenopausal women. Clinical
data concerning this point (Table I I ) were recently collected by the authors. Levels
Table I I
Estrogen Effects on Vaginal Epithelia
Clinical

No.

Categories

Subjects

Cytologic Rating*
A

B

C

D

Normals

58

12.0

44.8

32.8

10.4

Osteoporosis

27

.1.7

17.8

55.6

22.9

Breast Cancer

58

0.0

31.0

34.5

34.5

*Per cent distribution, adjusted for time after menopause
A=cornified and noncornified superficial cells
D=basal and parabasal cells
B and C=intermediate groups

of estrogen effect were judged by the degree of maturity of the vaginal epithelium,
and two groups of patients (breast cancer and osteoporosis) were compared to
contemporary normal subjects who had been found free of any neoplasm at a
large cancer detection clinic. While a relatively high percentage of all subjects
maintain mature epithelia years after the menopause, differences of probable significance were found between normals and the two patient groups. Whatever the
source of estrogens in postmenopausal women it appears that they are of some
biological importance to the host. An understanding of hormonal functions of the
elderly is at least equal in importance to problems concerning reproduction and
fertility, because these functions bear heavily on such complications of the aging
process as osteoporosis, atherosclerosis and carcinoma.
Progesterone has two important roles, as an intermediate in corticoid, androgen
and estrogen biosynthesis, and as a hormone secretion itself. As a major intermediate
in the biosynthesis of adrenocorticoids, progesterone normally undergoes a rapid
hydroxylation at Ci? with only small amounts excreted in urine as the pregnanediol
derivative. However, selective enzymatic deficiencies in the adrenal cortex may
result in failure of hydroxylation at C21, as in the syndrome of congenital adrenal
virilism. Under these conditions of impaired Cortisol synthesis and compensatorily
increased ACTH release, the accelerated adrenal steroidogenesis produces 17-hydroxyprogesterone in large amounts. This latter compound is reduced and excreted
as pregnanetriol in urine, one of the biochemical hallmarks of the adrenogenital
syndrome.
Progesterone is considered phylogenetically to have become significant in reproductive physiology when ovoparity was superseded by viviparity in the animal
kingdom." Its metabolism to pregnanediol, the major excretion product in urine,
involves a series of reduction steps. The four pregnanediol isomers represent only
one group of the several urinary metabolites that have been identified. Pregnanediol,
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excreted as a glucuronide conjugate, can be recovered in the urine during the luteal
phase of the menstrual cycle in amounts of approximately 2 to 4 mg, daily.
Many of the concepts concerning mechanisms of steroid synthesis in ovary and
testis have been derived to a great extent from in vitro studies of human tumor
tissue. The hazard of error is great in assuming that knowledge of hormone biosynthesis by tumors can be applied fully to function of the normal human gonad.
Competent pathologists and endocrine histologists admit the difficulties of distinguishing,
for instance, luteomas from Leydig cell tumors, and these from certain adrenocortical
tumors arising from adrenal rests in the gonad. There have been reports'' in recent
years of gonadal tumors synthesizing steroids hydroxylated at the Cn position, which
might suggest that the gonads normally contain an 11-/3 hydroxylating enzyme, as
does the adrenal cortex for the biosynthesis of the glucocorticoids. There is yet no
evidence for this in the normal gland, however. The critical issue in such studies
of gonadal tumors is which method, the histological or biochemical, will be accepted
as the final determinant of whether the tumor was derived from gonadal or displaced
adrenal tissue.
As to the human in vivo studies most data have been derived chiefly from
analyses of excretory products. Until more is known of metabolic pathways, blood
concentrations, gonadal blood flow and the renal handling of steroids and their
metabolites, it will be difficult to describe with any precision the steroid productivity
of the gonads.
In addition to the gonadal steroids there is one non-steroid hormone of the
ovary, relaxin, which can be given passing recognition. This substance has been
demonstrated only during pregnancy, and apparently is of both ovarian and placental
origin. Hisaw" in 1929 first isolated relaxin from corpus luteum extracts and
defined its action in the softening and relaxation of pelvic ligaments of parturient
rodents. The results of several clinical studies concerning the efficacy of relaxin
in the treatment of premature labor'"-" have been conflicting.
HORMONAL INTERRELATIONSHIPS
The gonads have long been viewed as victims of thyroidal and adrenal dysfunction,
yet much of the accusation has been based on highly circumstantial clinical evidence,
particularly in respect to the thyroid. Despite the almost overwhelming clinical
testimony, fortunately not all published, regarding the therapeutic elTicacy of desiccated thyroid in disturbances of gonadal function, there have been few scientific
demonstrations of an intimate interrelationship. It has been claimed that patients
with untreated myxedema have prominent ovarian cysts, and Janes'"" reported a
high incidence of cystic ovaries in rats with long-standing induced hypothyroidism.
Meites'" has shown that such animals are more responsive to chorionic gonadotropin,
which seems to exhibit more FSH-Iike action in the hypothyroid animal than in the
euthyroid. Beierwaltes"' found normal amounts of gonadotropins in the urine of
myxedematous women, an observation confirmed in our laboratory in the assay of
urine from postmenopausal women with spontaneous myxedema. Goldsmith and
associates'" have studied the menstrual pattern of women with disturbed thyroid
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function. In 70 per cent of patients with hyperthyroidism, ovulation occurred regularly,
yet practically all had a marked degree of oligomenorrhea. Seven of ten premenopausal
females with myxedema demonstrated ovulatory failure, while two had normal
ovulation and menses. A l l were restored to normal menstrual cycles after proper
treatment with desiccated thyroid. The investigators considered the menstrual defects
to be the result of inadequate production or effectiveness of the luteinizing hormone.
The evidence that the level of basal metabohc rate determines to a great
extent the rate of estrogen disposal is quite consistent with the frequently encountered
clinical observation of altered menstrual patterns in women with thyroid dysfunction.
The known acceleration of rates of estrogen conjugation and excretion in a thyroxininduced hypermetabolic environment may acount for the hypo- and oligomenorrhea
characteristic of the hyperthyroid female. Contrariwise, delayed metabolism of
estrogen in experimentally produced hypothyroidism is consistent with the menorrhagia
which often occurs in patients with myxedema. This important hormonal relationship
is probably liver dependent, since this organ is the major site of estrogen metabolism.
There is less evidence of significance relative to the effects of thyroxin on androgen
metabolism. However, in 1956 Bradlow and associates" reported high urinary etiocholanolone to androsterone ratios in myxedema patients, and a partial correction
toward normal when triiodothyronine was administered.
There is evidence that estrogens in turn can modify certain aspects of thyroid
function, although the biological significance of this relationship has not been defined.
The best example is the known action of estrogens to increase the concentration
of circulating protein-bound iodine. The demonstration of increased thyroxin-binding
protein, both in pregnancy and in estrogen-treated women, seems to explain the
phenomenon since the high PBI concentrations are unassociated with evidence of
an increased metabolic action of the circulating thyroxin. That the effect is dependent
on several factors is suggested by the studies of Stoddard and associates'" who
reported no consistent change in concentrations of serum precipitable iodine after
bilateral oophorectomy of women in their reproductive years, and of Engbring and
co-workers'" who have shown that the thyroid gland is not necessary for the estrogeninduced rise in PBI concentration. They concluded from their studies that the
increased PBI is due to a prolongation of the thyroxine survival time. Thus, the
sequence of action can be outlined as follows: 1) increased thyroxine-binding capacity
of serum; 2) increased concentration of PBI; 3) decreased utilization of thyroid
hormone; 4) decreased BMR; 5) increased pituitary secretion of TSH; 6) increased
thyroid gland activity. Testosterone, on the other hand, appears to lower serum
PBI levels, but the mechanism has not been defined.
Clinicians have postulated that the cycles of follicular and luteal activity in
the normal female, by virtue of sequential stimulation and suppression of hypophyseal
function, including TSH release, result in cyclic variations in thyroid function and
ultimately in goiter, nodular or otherwise. Experimental support of this concept in
man is lacking, however. Reineke and Soliman"' have reviewed evidence for a
functional interrelationship of thyroid and gonad in animals and demonstrated that
at estrus the metabolic rate is often maximal and, by the criterion of thyroidal uptake
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of r " , that thyroid function is also maximal. In ovariectomized rats, the administration
of small doses of estrogen results in an increased P" uptake by the thyroid.
Existence of a complex interrelationship between the gonad and adrenal may
be anticipated by virtue of the common embryologic origin of these glands. Clinical
endocrinologists in the past three or four years, recognizing the potential significance
to the ovary of adrenal function, normal and abnormal, have successfully used the
glucocorticoids in the treatment of ovarian dysfunction and infertility'"''"'™.
That an ovarian-adrenal relationship exists in the normal female is evident in
the conspicuous change in adrenocortical function which occurs in the years just
before and during menarche. The data shown in Figure 13 have been taken from
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Figure 13
Urinary 17-ketosteroid excretion from childhood to adolescence.
Summation of data from Nathanson^i and Oesting."
the well-known studies of Nathanson and associates,and Oesting and Webster."
The rise in urinary 17-ketosteroids from prepubertal levels of one or two milligrams
to adult levels of 14 or 16 milligrams represents an impressive alteration in adrenal
function brought on as a result of, or at least simultaneously with, the rise in ovarian
function. Evidence that these ketosteroids are adrenal and not ovarian in origin has
been previously cited. Reifenstein et al.=' once postulated that pituitary L H , released
in increasing amounts from the pituitary through the effects of estrogens from the
maturing ovary, resulted in the so-called adrenarche. This concept has never been
substantiated. Furthermore, recent evidence is available to indicate that chorionic
gonadotropin, possessing L H action, does not stimulate the adrenal cortex, judged
by levels of urinary 17-ketosteroids and 17-hydroxycorticoids." Patients with primary
hypogonadotropic hypogonadism and those with gonadal dysgenesis have been found
to excrete low levels of urinary 17-ketosteroids despite normal rates of glucocorticoid
biosynthesis."'"
Recently, several groups of investigators have shown an effect of estrogens on
one interesting aspect of adrenal function.'''" Administration of stilbesterol or ethinyl
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estradiol in moderate amounts to a normal person results in materially increased
levels in plasma of free 17-hydroxycorticoids. This phenomenon has been shown
to result from a decreased rate of corticosteroid reduction in liver and to an increased
plasma binding of Cortisol. However, in contrast to the increasing levels of urinary
17-ketosteroids observed during gonadal activation at puberty, the opposite effect
has been observed during estrogen administration. In Table I I I are data from our
Table I I I
Effect of Oral Estrogen in Nine Virilized Women.
17-KS
mg./24 hr.
mean ± S.E.

P value

None (22)

18.2 ± 1.7

—

Estrogen (26)

12.7 ± 1.7

0.05 — 0.02

Treatment
(No. of assays)

recent studies of a group of virilized women. In these subjects, 17-ketosteroid
excretion was observed to fall from 18.2 to 12.7 mg. during the ingestion of
Estinyl.® Hermann and associates'' have also observed reduced urinary 17-ketosteroids
during periods of estrogen administration. By fractionation analyses of the 17-ketosteroids, they found the decreased excretion to involve steroids of both adrenal and
gonadal origin. Furthermore, this phenomenon occurred in their study at physiologic
levels of administered estrogen.
In addition to suppressing gonadal steroidogenesis via inhibition of gonadotropin
release, administered estrogens could also lower urinary 17-ketosteroids by: 1) inhibiting the conversion of corticoids to 17-ketosteroids; 2) suppressing adrenal androgen
secretion through ACTH inhibition, via elevated titers of plasma Cortisol; and 3)
the increased plasma binding or altered metabolism of the androgen precursors
themselves. Since estrogen administration can reduce the urinary 17-ketosteroid
response to infused A C T H without altering the plasma Cortisol response, Hermann
and associates'" concluded that estrogens increase the plasma binding of 17-ketosteroid
precursors.
In several species, under both natural and experimental conditions, adrenal
hyperplasia has been induced by the administration of estrogens."-" This effect is
ACTH dependent, and Witschi" has postulated from his experiments that in the
amphibia at least, the hypothalamic-hypophyseal release mechanism, essential to
ovulation, is dependent not only on the gonadotropic but also on the adrenotropic
system. The postulated mechanism of ovulation is depicted in Figure 14. Whether
or not this observation applies to human females is problematical, but the presently
inexplicable successes reported to follow glucocorticoid administration to infertile,
non-virilized women may involve some such system.
Concerning the effect of the glucocorticoids on gonadal function, it might be
reasoned on ontogenetic ground that a condition of relative permissiveness exists,
since complex gonadal functions evolved under the influence of a much older adrenocortical system. That is, within physiological limits, changing adrenal function
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Figure 14
Endocrine interrelationships during ovulation in the amphibia. The postulated role of the
adrenotropic system is based on the observations of Witschi."

has only a minor effect on gonadal function. Clinical experience with patients having
adrenocortical insufficiency provides support for this concept, since undisturbed
gonadal function is often observed in patients with Addison's disease. In instances
of complete adrenocortical insufficiency, amenorrhea in women and impotence in
men may result, but the mechanism would seem to be an adaptation for survival
rather than a reflection of endocrine dependency. Continued ovulation and, indeed,
fertility with resulting pregnancy were not rare experiences for the Addisonian female
treated in the pre-cortisone era with sodium chloride and deoxycorticosterone. Continuation of pregnancy under these conditions may have been dependent to a great
extent on placental synthesis of glucocorticoids, although results in recent studies
do not support this idea."
Physicians have had a rich opportunity to observe the effects of increased
glucocorticoid levels on gonadal function as a result of the widespread use of
corticoids in clinical practice. Interference with function does occur, but is usually
observed quite late in the course of treatment, at least if conventional dosages are
used. Irregular menses, amenorrhea and reduced potency result, but they are not
common in otherwise healthy persons. With high dose glucocorticoid therapy
particularly for persons with systemic disease, the aforementioned effects are likely
to occur earlier. The beneficial results of glucocorticoid therapy in women with
ovarian dysfunction are considered due to improvement of pre-existing endocrine
abnormalities.
One action by which adrenal steroids could alter hypophyseal-gonadal function
was first reported by Sohval," and independently by Smith" in 1950. Markedly
increased levels of gonadotropins were observed in urine of patients receiving glucocorticoid or corticotropin therapy. The patients under study were in the initial
phases of treatment with conventional but physiologically abnormal doses of the
hormones. Gonadotropin titers were increased two to six fold in both studies. The
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mechanism remains unknown but increased renal clearance of the gonadotropin as
a result of the corticoid effect on kidney function is considered one explanation.
Whatever the basis, disturbed gonadal function manifested as amenorrhea and oligomenorrhea with anovulatory cycles, might be the anticipated result if the corticoid
effect on gonadotropin release were prolonged. Study of patients with Cushing's
syndrome provides conflicting evidence, since low or absent gonadotropin excretion
has been observed." These low titers may reflect the general protein depletion of
prolonged hypercorticism, with curtailment of gonadotropin formation such as occurs
in starvation. Although increased renal loss of gonadotropin may have occurred in
the early phases of the hypercorticism, there is no supporting data for this thesis.
However, lannaccone and associates" observed that ovaries of premenopausal Cushing's
patients were small and white, with diminished follicular activity. Primordial follicles
were sharply reduced and the overall picture was that of premature aging. These
observers cited no gonadotropin data, stating that "disordered pituitary gonadotropic
function cannot be excluded as a possible contributory cause". It seems likely that
depleted gonadotropin secretion could have been a very important factor even though
the ovaries histologically were not much different from those seen in postmenopausal
women with high gonadotropin output.
This essay, keyed to the clinically oriented reader, is an attempt to integrate
established knowledge with certain of the recent contributions in the study of
gonadal development and function, particularly as it relates to man. Without question,
some areas of the broad subject have been insufficiently discussed, and of the many
available references, only a few have been cited. For more extensive information,
the reader may turn to several monographs and texts recently published."'™" Just
as in the case of insulin, therapeutic triumphs in clinical endocrinology are often
achieved before the modus operandi are known. Yet the past ten years of accumulating
insight regarding adrenal pathophysiology and biochemistry have prepared the way
for gaining the more elusive knowledge concerning the gonads. A broad conceptual
framework of gonadal form and function is helpful for understanding the contributions
to come. The present review may serve this purpose for those not intimately concerned with endocrine research.
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